110 related articles for article (PubMed ID: 8409391)
21. Coelomocytes express SpBf, a homologue of factor B, the second component in the sea urchin complement system.
Smith LC; Shih CS; Dachenhausen SG
J Immunol; 1998 Dec; 161(12):6784-93. PubMed ID: 9862709
[TBL] [Abstract][Full Text] [Related]
22. CRIT peptide interacts with factor B and interferes with alternative pathway activation.
Hui KM; Magnadóttir B; Schifferli JA; Inal JM
Biochem Biophys Res Commun; 2006 May; 344(1):308-14. PubMed ID: 16600177
[TBL] [Abstract][Full Text] [Related]
23. Chicken prion tandem repeats form a stable, protease-resistant domain.
Marcotte EM; Eisenberg D
Biochemistry; 1999 Jan; 38(2):667-76. PubMed ID: 9888807
[TBL] [Abstract][Full Text] [Related]
24. Expression of functional recombinant von Willebrand factor-A domain from human complement C2: a potential binding site for C4 and CRIT.
Hui KM; Orriss GL; Schirmer T; Magnadóttir B; Schifferli JA; Inal JM
Biochem J; 2005 Aug; 389(Pt 3):863-8. PubMed ID: 15823096
[TBL] [Abstract][Full Text] [Related]
25. Calnexin is associated with and induced by overexpressed human complement protein C2.
Tsukamoto H; Tousson A; Circolo A; Marchase RB; Volanakis JE
Anat Rec; 2002 May; 267(1):7-16. PubMed ID: 11984787
[TBL] [Abstract][Full Text] [Related]
26. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
[TBL] [Abstract][Full Text] [Related]
27. Structure and assembly of the catalytic region of human complement protease C1r: a three-dimensional model based on chemical cross-linking and homology modeling.
Lacroix M; Rossi V; Gaboriaud C; Chevallier S; Jaquinod M; Thielens NM; Gagnon J; Arlaud GJ
Biochemistry; 1997 May; 36(21):6270-82. PubMed ID: 9174342
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneous nature of human complement factor B: an electrophoretic approach for the analysis of its oligosaccharide chain structure and its physiological breakdown products.
Garnier G; Davrinche C; Charlionet R
Electrophoresis; 1989 Jul; 10(7):501-12. PubMed ID: 2776735
[TBL] [Abstract][Full Text] [Related]
29. Fasciola hepatica: characterization and cloning of the major cathepsin B protease secreted by newly excysted juvenile liver fluke.
Wilson LR; Good RT; Panaccio M; Wijffels GL; Sandeman RM; Spithill TW
Exp Parasitol; 1998 Feb; 88(2):85-94. PubMed ID: 9538862
[TBL] [Abstract][Full Text] [Related]
30. Purification and properties of a coagulant thrombin-like enzyme from the venom of Bothrops leucurus.
Magalhães A; Magalhães HP; Richardson M; Gontijo S; Ferreira RN; Almeida AP; Sanchez EF
Comp Biochem Physiol A Mol Integr Physiol; 2007 Apr; 146(4):565-75. PubMed ID: 16481207
[TBL] [Abstract][Full Text] [Related]
31. Limited proteolysis of complement components C2 and factor B. Structural analogy and limited sequence homology.
Kerr MA
Biochem J; 1979 Dec; 183(3):615-22. PubMed ID: 261515
[TBL] [Abstract][Full Text] [Related]
32. Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida albicans.
Held K; Thiel S; Loos M; Petry F
Mol Immunol; 2008 Sep; 45(15):3934-41. PubMed ID: 18672286
[TBL] [Abstract][Full Text] [Related]
33. The alternative complement pathway in chickens. Purification of factor B and production of a monospecific antibody against it.
Koch C
Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):253-9. PubMed ID: 3646826
[TBL] [Abstract][Full Text] [Related]
34. Conformational changes during the assembly of factor B from its domains by (1)H NMR spectroscopy and molecular modelling: their relevance to the regulation of factor B activity.
Hinshelwood J; Perkins SJ
J Mol Biol; 2000 Sep; 301(5):1267-85. PubMed ID: 10966820
[TBL] [Abstract][Full Text] [Related]
35. Macrophages synthesize and secrete a 25-kilodalton protein that binds insulin-like growth factor-I.
Li YM; Arkins S; McCusker RH; Donovan SM; Liu Q; Jayaraman S; Dantzer R; Kelley KW
J Immunol; 1996 Jan; 156(1):64-72. PubMed ID: 8598495
[TBL] [Abstract][Full Text] [Related]
36. The principal site of glycation of human complement factor B.
Niemann MA; Bhown AS; Miller EJ
Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):473-80. PubMed ID: 2006911
[TBL] [Abstract][Full Text] [Related]
37. Activation of the C4 and C2 components of complement by a proteinase in serum bactericidal factor, Ra reactive factor.
Ji YH; Fujita T; Hatsuse H; Takahashi A; Matsushita M; Kawakami M
J Immunol; 1993 Jan; 150(2):571-8. PubMed ID: 8419490
[TBL] [Abstract][Full Text] [Related]
38. Molecular isoforms of cobra venom factor-like proteins in the venom of Austrelaps superbus.
Rehana S; Manjunatha Kini R
Toxicon; 2007 Jul; 50(1):32-52. PubMed ID: 17412383
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
40. Comparison of prostaglandin H synthase isoform structures using limited proteolytic digestion.
Guo Q; Chang S; Diekman L; Xiao G; Kulmacz RJ
Arch Biochem Biophys; 1997 Aug; 344(1):150-8. PubMed ID: 9244392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
